TABLE 1

Biodistribution of anti-ICAM/ASM vs. IgG/ASM nanocarriers in mice

Blood and organ levels of 180-nm-diameter polystyrene particles carrying 125I-ASM and either anti-ICAM or control IgG 30 min after i.v. injection in anesthetized C57Bl/6 mice. Data are mean ± S.E.M. (n ≥ 6 mice).



Blood

Kidney

Heart

Liver

Spleen

Lung

Anti-ICAM
IgG
Anti-ICAM
IgG
Anti-ICAM
IgG
Anti-ICAM
IgG
Anti-ICAM
IgG
Anti-ICAM
IgG
%ID 4.1 ± 0.4 3.4 ± 0.3 1.4 ± 0.05* 0.9 ± 0.1 0.4 ± 0.03 0.3 ± 0.04 39.0 ± 2.8*** 58.9 ± 1.9 4.0 ± 0.4 4.6 ± 0.9 22.8 ± 3.0*** 0.9 ± 0.2
%ID/g 2.6 ± 0.3 2.0 ± 0.1 4.7 ± 0.2** 3.2 ± 0.5 3.7 ± 0.3 3.1 ± 0.5 36.4 ± 2.8** 53.9 ± 2.6 47.3 ± 5.1 58.2 ± 14.2 140.8 ± 17.0*** 6.9 ± 1.5
LR 2.0 ± 0.2 1.3 ± 0.4 1.6 ± 0.2 1.1 ± 0.2 16.6 ± 2.5 20.0 ± 4.6 22.3 ± 3.8 20.7 ± 7.8 61.5 ± 11.3*** 2.9 ± 1.1
Specificity index


1.5

1.5

0.8

1.1

21.3

  • * p < 0.05, ** p < 0.01, and *** p < 0.001 (Student's t test).